Insider Selling: Alphatec (NASDAQ:ATEC) COO Sells $3,204,580.50 in Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC) COO Scott Lish sold 260,535 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an average price of $12.30, for a total transaction of $3,204,580.50. Following the completion of the transaction, the chief operating officer owned 815,704 shares of the company’s stock, valued at approximately $10,033,159.20. This represents a 24.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Alphatec Price Performance

Shares of Alphatec stock opened at $12.73 on Friday. The firm has a market cap of $1.93 billion, a P/E ratio of -13.40 and a beta of 1.02. The firm’s 50-day simple moving average is $14.37 and its 200-day simple moving average is $16.78. Alphatec Holdings, Inc. has a twelve month low of $8.81 and a twelve month high of $23.29. The company has a debt-to-equity ratio of 40.35, a quick ratio of 1.28 and a current ratio of 2.06.

Alphatec (NASDAQ:ATEC) last posted its earnings results on Tuesday, February 24th. The medical technology company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The company had revenue of $212.93 million for the quarter, compared to the consensus estimate of $212.67 million. During the same quarter last year, the business earned ($0.23) EPS. Alphatec’s quarterly revenue was up 20.4% compared to the same quarter last year. As a group, research analysts expect that Alphatec Holdings, Inc. will post -1.08 EPS for the current fiscal year.

Hedge Funds Weigh In On Alphatec

Institutional investors have recently modified their holdings of the stock. Aster Capital Management DIFC Ltd bought a new stake in shares of Alphatec during the third quarter valued at approximately $34,000. Osterweis Capital Management Inc. acquired a new stake in shares of Alphatec in the second quarter valued at approximately $37,000. Northwestern Mutual Wealth Management Co. raised its position in Alphatec by 157.1% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,571 shares of the medical technology company’s stock worth $54,000 after purchasing an additional 1,571 shares during the last quarter. China Universal Asset Management Co. Ltd. acquired a new position in Alphatec during the 3rd quarter worth $73,000. Finally, FNY Investment Advisers LLC acquired a new position in Alphatec during the 3rd quarter worth $74,000. 66.35% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Loop Capital set a $25.00 price target on shares of Alphatec in a report on Wednesday, December 10th. Barclays lifted their target price on shares of Alphatec from $23.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, January 7th. Wall Street Zen raised Alphatec from a “hold” rating to a “buy” rating in a report on Saturday, January 31st. Piper Sandler restated an “overweight” rating on shares of Alphatec in a research report on Wednesday, February 25th. Finally, TD Cowen reaffirmed a “buy” rating on shares of Alphatec in a report on Tuesday, January 27th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Alphatec currently has an average rating of “Moderate Buy” and a consensus target price of $22.82.

Alphatec Company Profile

Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.